Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06256458 · ClinicalTrials.gov registry record
Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma
A clinical trial of Fractures, Bone, sponsored by Artoss.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06256458: Recruiting study of Fractures, Bone, sponsored by Artoss.
NCT06256458 is a study of Fractures, Bone that is actively recruiting participants, run by Artoss. The registered enrollment target is 200 participants, below the 1,929-participant average among 12 other Fractures, Bone trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06256458, a study of Fractures, Bone, is actively recruiting participants, sponsored by Artoss.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This multicenter prospective patient registry was developed with the aim of documenting how orthopedic surgeons are utilizing the NanoBone products in acute trauma cases along with relevant patient outcomes. These outcomes include radiographic measures such as fracture healing, instrumentation integrity, and clinical outcomes (symptom and function improvement) based on investigator and patient-based outcome assessments.
Primary Outcome
AP and lateral x-rays
Conditions Studied
Interventions
- DEVICE NanoBone® Bone Graft
Study Locations (1)
Wisconsin
- SSM Health St. Mary's Hospital - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2026-12-01 |
What NCT06256458 shows while recruiting
NCT06256458 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,929-participant average among 12 other Fractures, Bone trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Fractures, Bone appearing as the primary indexed condition, and to 1 intervention - of which NanoBone® Bone Graft is the first listed.
NCT06256458 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06256458 about?
NCT06256458 is a clinical study titled "Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma". This multicenter prospective patient registry was developed with the aim of documenting how orthopedic surgeons are utilizing the NanoBone products in acute trauma cases along with relevant patient outcomes. These outcomes include radiographic measures such as fracture healing, instrumentation integ...
What is the current status of trial NCT06256458?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-12-01. Estimated completion is 2026-12-01.
What conditions does trial NCT06256458 study?
This clinical trial studies the following conditions: Fractures, Bone.
What interventions are being tested in trial NCT06256458?
The interventions under investigation include: NanoBone® Bone Graft (DEVICE).
Who is sponsoring clinical trial NCT06256458?
This trial is sponsored by Artoss, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06256458 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fractures, Bone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06256458's enrollment target sits among peer trials
200 4th of 12 higher than 9 of 12 other Fractures, Bone trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fractures, Bone trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk
RECRUITING
-
PAINED: Project Addressing INequities in the Emergency Department
RECRUITING · NA
-
Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care
RECRUITING
-
Virtual Reality During Pediatric Cast Removal
RECRUITING · NA
-
Cast Art for Kids With Extremity Fractures
RECRUITING · NA
-
Continuous Passive Motion Following Fixation of Pelvic and Knee Fractures
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI